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Abstract
Central precocious puberty may result from organic brain lesions, but is most frequently of idiopathic origin. Clinical or
biochemical factors which could predict a pathological brain MRI in girls with CPP have been searched for. With the recent
decline in age at pubertal onset among US and European girls, it has been suggested that only girls with CPP below 6 years
of age should have brain MRI performed.
Objective: To evaluate the outcome of brain MRI in girls referred with early signs of puberty in relation to age at
presentation as well as clinical and biochemical parameters.
Method: A single-center study of 229 consecutive girls with early or precocious puberty who had brain imaging performed.
We evaluated medical history, clinical and biochemical factors, and four groups were defined based on the outcome of their
MRI.
Results: Thirteen out of 208 (6.3%) girls with precocious puberty, but no other sign of CNS symptoms, had a pathological
brain MRI. Importantly, all 13 girls were above 6 years of age, and 6 girls were even 8–9 years old. Twenty girls (9.6%) had
incidental findings on brain MRI. Furthermore, 21 girls had known CNS pathology at time of evaluation. Basal LH was
significantly higher in girls with newly diagnosed CNS pathology compared to girls with a non-pathological MRI (p=0.025);
no cut of value was found as values overlapped.
Conclusion: A high frequency of 6–8 year old girls with precocious puberty in our study had a pathological brain MRI, which
could not be predicted from any clinical nor biochemical parameters. Thus, we believe that girls with precocious pubertal
development of central origin before 8 years of age should continue to be examined by a brain MRI.
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Introduction
True precocious puberty in girls is defined by the development
of secondary sexual characteristics before the age of 8 years [1–3],
and is accompanied by growth acceleration, advancement of bone
age and elevated sex steroid levels. Precocious puberty secondary
to the activation of the hypothalamic-pituitary-gonadal axis
(gonadotropin-dependent) is termed central precocious puberty
(CPP). Recent studies find that only a minority of cases with CPP
in girls is caused by central nervous system (CNS) abnormalities,
i.e. organic CPP (OCPP) [4–11]. Importantly, magnetic resonance
imaging (MRI) has until today been performed to rule out brain
abnormalities in all girls with CPP. The most frequently detected
brain abnormalities associated with CPP include hypothalamic
hamartomas, optic gliomas, astrocytomas, pineal tumours, post-
infectious encephalitis, hydrocephalus, neurofibromatosis and
previous CNS injury [6,9,12,13].
Recent studies have evaluated clinical and biochemical
predictors to ensure early identification of girls with brain
abnormalities. A French study of 197 girls with precocious
puberty from a single-center suggested that chronological age
lower than 6 years or the combination of chronological age older
than 6 years and a serum concentration of estradiol (E2) above
45 pmol/L was predictive of OCPP [14]. This algorithm was
verified in a European multi-center cohort study which included
443 girls from seven different centers, although hormone assays
varied among centers [8].
In a recent study of Caucasian girls referred with early signs of
puberty, we found that levels of basal luteinizing hormone (LH)
could partly predict the outcome of GnRH-testing. Furthermore,
we found that estradiol levels were above +2 SD in 86% of girls
with OCPP compared to 46% of girls with idiopathic CPP [4]. So
far, no single clinical or biochemical predictor of a pathological
brain MRI in girls with CPP has been identified, although young
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e29829age, rapid progression and high estradiol levels are considered
factors which may predict higher risk of brain abnormalities
[3,14]. Also body mass index (BMI), bone age advancement, peak
LH, peak follicle-stimulating hormone (FSH) and LH/FSH levels
have been proposed as factors which may identify girls at high risk
of OCPP [7]. Though, the concern remain by the potential risk of
missing treatable brain abnormalities from leaving out MRI in low
risk girls, including 6–8 year old girls [5,7,10,15,16]. The recent
downwards changes in age at pubertal onset in US and Europe
[17,18] may theoretically challenge the appropriate age limit from
which girls with CPP should have a brain MRI performed.
The aim of this study is to evaluate the outcome of brain MRI in
229 consecutive girls referred with early signs of puberty, and to
evaluate possible predictive factors in girls with pathological brain
MRI outcome.
Methods
Patient population
We included girls referred because of clinical signs of early or
precocious puberty to our tertiary referral university department at
Rigshospitalet in Copenhagen, Denmark, during a 16-year period
from January 1
st 1993 to January 31
st 2009. Patients were
recorded in our centralized register upon referral with a diagnosis
according to the World Health Organization’s International
Classification of Diseases, Tenth Revision (ICD-10) in our
department. The referral diagnoses included central precocious
puberty (DE288A), premature thelarche (DE308A), premature
adrenarche (DE270B) and early-normal pubertal variant (DE301).
To make sure we included all girls referred with precocious
puberty we also included girls primarily coded with an
observational diagnosis code (DZ038 or DZ003) in combination
with an additional ICD-10 code related to early puberty. We
evaluated the girls with pubertal onset before 9 years of age based
on available reference data from 1991 on pubertal timing in
healthy Danish girls [19]. Furthermore, to complete the cohort
and make this study clinically representative, we included girls
referred to our department with pubertal onset even after the age
of 9 as previously described [4]. Altogether 786 consecutive girls
were referred of whom 47 patient’s files were lost to follow up. Of
the 739 girls referred for evaluation, 239 had imaging of the brain
performed. Out of these 239 girls, 10 girls were excluded because
of insufficient data resulting in a cohort of 229 girls.
Hormone analyses
Non-fasting venous blood samples were obtained from all girls
to determine FSH, LH and estradiol. All reproductive hormones
were determined in duplicates in our own hormone laboratory
using the same methods during the entire study period. LH and
FSH were measured by ultrasensitive time-resolved immuno-
fluorometric assays (DelfiaH, Wallac, Inc., Turku, Finland) [20].
The detection limits for LH, FSH were 0.05 IU/L and 0.06 IU/L,
respectively. Estradiol was measured by radioimmunoassay with a
detection limit of 18 pmol/l (Pantex, Santa Monica, CA [before
1998 distributed by Immuno Diagnostic System, Bolden, United
Kingdom]) [20].
Clinical examination
The clinical examination included a full history from the patient
and her family, followed by an examination of pubertal
development according to the Marshall and Tanner criteria
[21], including both inspection and palpation of glandular breast
tissue. Height and weight were measured, BMI was calculated as
weight/height
2, and the respective standard deviation scores (SDS)
were calculated based on Danish reference data [22,23]. Bone age
was assessed by X ray of left hand according to Greulich and Pyle
[24].
GnRH test
A gonadotropin-releasing hormone (GnRH) stimulation test was
performed in 188 girls. Serum LH and FSH were determined 0
and 30 minutes after the intravenous bolus administration of
GnRH (100 mg Relefact, Sanofi-Aventis, Frankfurt am Main,
Germany). In accordance with guidelines [3], we defined CPP by:
1) peak LH$5 IU/L or 2) stimulated FSH/LH ratio $0.66 IU/L
or 3) if GnRH test was not performed the hormone level was
considered pubertal if basal LH levels above 0,3 IU/L according
to Neely et al. [25].
Brain magnetic resonance imaging
All girls included had brain imaging performed by magnetic
resonance imaging (MRI) (n=207) or alternatively by computed
tomography (CT) (n=22) performed. CT was made when
contraindications were present (e.g. presence of cochlea trans-
plants or claustrophobia). The MRI findings were categorized into
4 groups; 1) well known brain aetiology at time of referral, 2) newly
diagnosed CNS pathology, including girls with early or precocious
puberty and no other CNS symptom, 3) incidental findings, not
associated to precocious puberty, 4) if the MRI showed normal
anatomy of the hypothalamic region and no incidental findings in
general, it was grouped as normal MRI.
Ethical considerations. The part of study regarding the
healthy children serving as controls was approved by the ethical
committees of the Capital Region (KF 01 282214 and
V200.1996/90) and conducted in accordance with the second
Helsinki Declaration. All children and guardians gave their
informed written consent to the study. The clinical part of the
present study is a retrospective evaluation of clinical information
from case record files that does not involve renewed contact with
the patients, and must in accordance with Act 2003-05-28 no. 402
be defined as a retrospective study, solely entailing registration of
specific data regarding the patient. Parents of the patients (all
,18 yrs) gave their informed written consent to the diagnostic
procedures and subsequent treatment.
Statistical analyses
The statistical analyses were made using the SPSS software
(Version 17.0; SPSS, Inc., Chicago, IL). Diagnostic groups were
compared using nonparametric Mann-Whitney U test, and a
probability value of p#0.05 was considered statistically significant.
Results
Brain MRI was performed in 229 girls. Cerebral findings were
abnormal in 54 patients (Table 1). Twenty one girls had well
known brain pathologies at the time of referral. In the remaining
208 girls with early or precocious puberty, who had no CNS
symptoms, MRI revealed CNS abnormalities in 33 girls. In 13
girls, the newly found MRI abnormalities (6.3%) were considered
to be causally related to the early puberty, and in another 20 girls
(9.6%) MRI findings were considered as incidental findings, which
were not related to the early puberty. The newly diagnosed
pathological findings included: arachnoid cysts (n=5), of which
one had hydrocephalus as well, hypothalamic hamartoma (n=1),
pilocytic astrocytoma (n=1), hydrocephalus and corpus callosum
agenesia (n=1), hamartomas (basal ganglia, brainstem, cerebel-
lum) and neurofibromatosis type 1 (NF1) (n=1), pineal tumour
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occipital lobe (n=1) and pontine tumour (n=1).
Girls with newly diagnosed CNS pathology
As shown in Table 2, nine of the 13 girls with newly diagnosed
brain pathology were treated with GnRH agonists, whereas
treatment was not indicated in three of the girls, and one did not
receive therapy due to parental decline. Ten girls had two or more
MRI scans performed during follow up. The three girls who were
scanned only once had congenital malformations (Chiari II
malformation, corpus callosum agenesia) or hamartomas in
relation to a newly diagnosed NF1, and had clinical follow up in
our department or in other paediatric departments. One girl with
a pilocytic astrocytoma was operated due to tumour growth, which
necessitated performing a hypophysectomy resulting in panhypo-
pituitarism. Another girl, with hypothalamic hamartomas, is still
being observed by repeated MRI scans not revealing tumour
growth. Representative MRI scans are illustrated in Figure 1.
Girls with incidental CNS findings
Twelve of the girls were treated with GnRH analogs. Twelve
out of the 20 girls with incidental findings had two or more MRI
scans during follow up. None of the girls underwent surgery.
Representative MRI scans are illustrated in Figure 2.
Girls with known CNS aetiology
The girls referred with known aetiology showed a broad
spectrum of pathologies related to precocious puberty which
include chiari malformation and myelomeningocele (MMC)
(n=4), hamartomas/gliomas and NF1 (n=3), astrocytomas
(n=3), encephalitis sequelae (n=2), hydrocephalus (n=2) and
another 7 girls with various abnormalities (see Table 1).
Clinical and biochemical predictors of a pathological MRI
As shown in Table 3 medical history, clinical and biochemical
factors were compared within the groups. In the total cohort, 161
girls had pubertal onset before 8 years whereas 68 girls were older
than 8 years at pubertal onset, resulting in a median age for
pubertal onset of 7.7 years (range 0.4 to 10.0). Median ages at
pubertal onset were 7.6 years (range 6.2 to 8.5), 7.7 years (range
2.5 to 10.0), 7.5 years (range 1.0 to 9.5) and 7.7 years (range 0.4 to
9.1) in girls with newly diagnosed CNS pathology, known CNS
abnormalities, incidental CNS findings and with a normal MRI,
respectively. Six girls with newly diagnosed CNS pathology had
pubertal onset after 8 years of age.
Basal LH was significantly higher in girls with newly diagnosed
CNS pathology both comparing to normal scans only and to all
non-pathological scans (p=0.023 and p=0.025, respectively).
Furthermore, both basal LH and peak LH levels were significantly
higher comparing all girls with pathological MRI scans(both newly
diagnosed and known at time of referral) to all girls with non-
pathological MRI scans (p=0.031 and p=0.043, respectively) (see
Table 3). Height, expressed as SDS, was significantly lower in girls
with pathological MRI compared to girls with non-pathological
MRI (p=0.047). No other parameters showed statistical differ-
ences. In terms of ethnicity 131 girls were of Danish origin, 37
were immigrants, 41 foreign-adopted and 20 had no information
of ethnic origin in the patient file. In the group of girls with newly
diagnosed CNS pathology two girls (ID 1 and 10, Table 2) were
adopted and another two girls (ID 9 and 12, Table 2) were
immigrants. Three girls who immigrated and one adopted girl had
known CNS aetiology at time of referral.
A total of 104 girls had true precocious puberty according to
international criteria (B2#8 years and a pubertal GnRH
response), out of whom 6 girls had OCPP based on newly
diagnosed pathology and further 6 had OCPP based on known
aetiology at time of referral. Median age at onset was 7.6 years (0.4
to 9.1) and 7.0 years (6.2 to 7.6) for girls with idiopathic CPP
(ICPP) and newly diagnosed OCPP respectively, but this
difference did not reach statistical significance (p=0.058).
Discussion
In this single-center cohort of 229 consecutive girls with early or
precocious puberty, 34 had pathological CNS findings. Out of
these, 21 were known CNS pathologies at time of referral.
Importantly, 13 out of 208 girls with central precocious puberty
and no other CNS symptoms presented with CNS pathologies
upon MRI which were causally related to CPP. Another 20 girls
presented with incidental findings.
Based on the MRI findings of pathological abnormalities
associated to CPP from other studies, we know that some of the
most common abnormalities include hypothalamic hamartomas,
Table 1. Anatomical description of 54 brain MRI with abnormal findings.
Newly diagnosed CNS pathologies 13 Known CNS ethiologi 21 Incidental findings 20
Arachnoid cysts 5 Chiari II malformations and MMC 4 Pineal cysts 5
Hamartomas 2 Hamartoma/glioma and NF1 3 Pituitary microadenomas 4
Pilocytic astrocytoma 1 Astrocytomas 3 Pituitary enlargement 3
Hydrocephalus and corpus callosum agenesia 1 Encephalitis sequelae 2 Pituitary enlargement 2
Pineal tumour 1 Hydrocephalus 2 Asymmetric pituitary 1
Chiari II malformation 1 Meningitis sequelae 1 Absent septum pellucidum 1
Cortical dysplasia in left occipital lobe 1 Arachnoid cyst and septo-optic dysplasia 1 Variation of perivascular space (normal) 1
Pontine tumour 1 Traumatic CNS injury 1 Unspecific white matter lesion 1
Brainstem tumour 1 Hyperintense thalamic lesion 1
Germinoma 1 Bone proces (clivus) 1
Porencephalic congenital cyst, hydrocephalus 1
Insult in left temporoparital region 1
doi:10.1371/journal.pone.0029829.t001
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that many other pathologies are associated to CPP (see overview in
Table 4). We found 6 girls presenting with arachnoid cysts, one
diagnosed prior to time of referral. The mechanism by which
arachnoid cysts induce central activation of the hypothalamic-
pituitary-gonadal axis remain unknown, but it has been suggested
that the hypothalamic area is especially sensitive to compression,
which also explains how hydrocephalus may cause CPP
[11,26,27]. Four girls presented with astrocytomas, three being
known at time of referral, which accounts for 12% of the CNS
pathologies. Two girls presented with optic gliomas and NF1, one
having hamartomas in capsula interna as well. Optic gliomas are
known to cause CPP. Precocious puberty is frequently seen among
patients with NF1 and optic pathway tumours [28]. Furthermore,
NF1 is associated with hamartomas which were found in two girls
with known pathology at time of referral. One girl presenting with
precocious puberty without any other CNS symptom was diagnosed
with NF1 after MRI findings of hamartomas and the finding of cafe
au lait spots at clinical examination. Hamartomas are non-neoplastic
heterotopias that initiates the rise in GnRH, and the malformation is
a well known aetiology of precocious puberty, although the exact
mechanism is still unidentified [10,11]. Surprisingly, only one girl in
our cohort was diagnosed with hypothalamic hamartomas, which
contrasts a number of other studies [8,16,29].
We found 20 girls presenting with incidental findings on their
brain MRI, which were not considered related to early pubertal
development. Such findings, although incidental, usually cause
considerable parental concern, but also in many cases repeated
MRI scans. More than half the girls in our study had at least two
control scans, which include general anaesthesia in some cases.
Incidental findings are reported in other studies [5,8,30], but the
psychological impact on the involved girls and their parents is,
although well known to clinicians, not reported in publications to
our knowledge. Unfortunately, there are currently no predictive
clinical or biochemical parameters that could assist clinicians in
avoiding this dilemma.
Figure 2. Brain MRI scans of girls with incidental findings. Typical incidental MRI findings in the CNS from three representative girls with early
or precocious puberty.
doi:10.1371/journal.pone.0029829.g002
Figure 1. Brain MRI of newly diagnosed pathology. Pathological brain MRI scans from 6 representative girls with precocious puberty and no
other CNS symptoms. ID indicating their identification number (see Table 2).
doi:10.1371/journal.pone.0029829.g001
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Basal LH levels, but not the GnRH stimulated LH/FSH ratio,
were significantly higher in girls with newly diagnosed CNS
pathology compared to girls with a normal brain MRI. Previously
we have found that basal LH levels is the superior biochemical
parameter to predict the outcome of a GnRH test [4]. This could
imply that the progression of puberty is faster in girls with organic
cause, although this is speculative. Likewise, serum estradiol levels
in girls were higher compared to girls with a normal MRI in
agreement with previous studies [8] although the difference did
not reach statistical significance.
True precocious puberty is traditionally defined by pubertal
onset before 8 years of age in girls. Our recent data from Denmark
showing a downwards secular trend in age at onset of breast
development could theoretically question the appropriate cut off
ages for performing a brain MRI [16]. Furthermore, the recent
data from US illustrates that a high proportion of otherwise
healthy 6–8 year old girls present with breast development [17].
However, in the Danish study we found that the early breast
development was not accompanied by pituitary-gonadal activa-
tion, and therefore concluded that the early-pubertal girls were
more likely to represent a thelarche-variant, which obviously do
Table 4. Summary of studies of precocious puberty.
Study Year Total
all
patologies Hamartomas
Astrocytomas/
Gliomas
Arachnoid
cysts Other
Incidental
findings
Organic
precocpis
puberty (%)
Bridges et al. 1994 91 6* 1 1 4 7
Chalumeau et al. (pilot) 2002 197 11 6 3 1 1 6
Chalumeau et al. (validation) 2002 42 3 3 7
Chalumeau et al. 2003 443 35 23 7 2 3 9 8
Chematily et al. 2001 230# 11 6 3 1 1 5
Choi et al. 2007 45 11 5 4 2 24
Cisternino et al. 2000 428 17 7 4 3 3 9 4
Kornreich et al. 1995 51 11 4 1 6 22
Ng et al. 2003 67 9 6 1 1 1 13
Soriano-Guile ´n et al. 2010 226 23 11 12 10
Taher et al. 2004 43 4 2 1 1 2 9
Mogensen et al. 2011 208# 13 2 1 5 5 20 6
Studies of girls with
known pathologies
Rivarola et al. 2001 12 12 4 3 4 1
Trivin et al. 2006 15 15 10 3 1 1
Trivin et al. 2006 52 52 20 5 27
Mogensen et al. 2011 21 21 3 3 1 14
*Previously diagnosed,
#only newly diagnosed.
doi:10.1371/journal.pone.0029829.t004
Table 3. Comparison of clinical and biochemical characteristics girls according to their brain MRI findings.
I Non-pathological II CNS Pathology IIb vs Ia II vs I IIb vs I
Ia Normal MRI
Ib Incidental CNS
abnormalities
IIa Known CNS
abnormalities
IIb Newly diagnosed
CNS Pathologies p-value p-value p-value
n 175 20 21 13
Age at onset 7,7 (0,4 to 9,1) 7.5 (1.0 to 9.5) 7,7 (2,5 to 10,0) 7,6 (6.2 to 8,5) 0.785 0.808 0.715
Age 1
st exam 8,5 (1,5 to 10,9) 8,5 (1,0 to 10,7) 8,5 (3,3 to 10,6) 9,0 (6.9 to 11,0) 0.196 0.819 0.187
BA-CA (years) 1,7 (21,8 to 4,3) 1,4 (2,5 to 2,9) 0,8 (21,4 to 6,1) 1,5 (21,0 to 3,1) 0.861 0.347 0.933
Height (SDS) 1,0 (23,2 to 4,8) 0,6(21,7 to 2,9) 0,1 (22,1 to 2,8) 1,1 (21,7 to 2,2) 0.938 0.047 0.952
BMI (SDS) 1,0 (22,7 to 4,9) 1.0 (21,9 to 2,7) 1,1 (20,4 to 3,5) 1,3 (0.1 to 2,8) 0.408 0.635 0.421
E2 (pmol/L) 42 (18 to 427) 37 (18 to 1052) 40 (18 to 401) 53 (18 to 611) 0.198 0.518 0.203
Basal LH (IU/L) 0,3 (0,05 to 9,4) 0,1 (0,05 to 15,3) 0,8 (0,05 to 6,7) 1,2 (0,06 to 5,5) 0.023 0.031 0.025
Peak LH (IU/L) 7,5 (0,2 to 77.9) 5,6 (1,7 to 21.1) 12,7 (1,0 to 50,1) 13.3 (1,6 to 63,3) 0.084 0.043 0.068
LH/FSH ratio 1,0 (0,1 to 9,8) 0,7 (0,2 to 2.1) 1,5 (0,1 to 6,8) 1,9 (0,3 to 3,72) 0.082 0.086 0.066
BA-CA: Bone age - Chronological age.
doi:10.1371/journal.pone.0029829.t003
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population, it may not necessarily apply to other populations. On
the other hand our present data clearly illustrates that brain MRI
abnormalities occur in girls referred with premature sexual
maturation in the 6–8 year age groups (and even in the 8–9 year
age group), especially in girls with rapidly progressive puberty and
biochemical signs of pituitary-gonadal activation. Thus, we believe
it would be wrong to change current recommendations of brain
MRI in girls with CPP before age 8, based on the finding of an
increasing incidence of a pubertal thelarche-variant in population-
based studies [16]. The typical clinical presentation encompass a
continuum from an early-normal and slowly progressing pubertal
variant to the rapidly progressing variant. Clinical follow up is
there mandatory before a decision on which patients to perform
GnRH testing and brain MRI can be taken.
Even though not statistically significant, age at pubertal onset
was still lower in girls with newly diagnosed OCPP compared to
girls with ICPP, which supports the hypothesis that age at pubertal
onset may be a positive predictor of OCPP. Using the diagnostic
tree presented by Chalumeau et al. [14], we would have missed
three girls with CNS pathology aged 6–8 years; one requiring
surgery (ID 3,4 and 6, Table 2). Interestingly, of the 68 girls who
had MRI performed with pubertal onset after 8 years of age, six
girls had newly diagnosed CNS pathology, none older than 8.5
years.
These data are unique as most other studies include girls only
up to 8 years [5–10,14,16,29–32]. Our results suggest caution
when using medical history as criteria for performing MRI, as also
girls older than 8 years at pubertal onset can present with
pathological brain abnormality.
It has previously been reported that foreign-adopted children
coming to Denmark has increased risk of precocious puberty [33].
In our study, even though finding 3 girls with CNS pathology, the
percentage of pathology is lower in foreign-adopted girls (7.3%)
than in girls with Danish origin and immigrants (15.3% and
13.5%, respectively). We believe that foreign-adoption could be a
negative predictor for CNS pathology, but further studies must be
made until making any final conclusions on this matter.
In conclusion, 13 out of 208 girls (6.3%) with early or precocious
pubertyandnootherCNSsymptomhad pathologicalCNSfindings
upon MRI, which were causally related to CPP. Importantly, all 13
girlswereabove 6 years ofage, and 6 girlswereeven8–9yearold. A
high frequencyof our6–8 year oldgirlswith early or precocious had
a pathological brain MRI, which could not be predicted from any
clinical or biochemical parameters in our study. Thus, we believe
that girls with precocious pubertal development of central origin
before 8 years of age should continue to be screened by brain MRI.
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